Virax Biolabs Group Limited Ordinary Shares (VRAX) Stock Price, Quote & AI Analysis
Live VRAX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Virax Biolabs Group Limited Ordinary Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for Virax Biolabs Group Limited Ordinary Shares (VRAX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Virax Biolabs Group Limited Ordinary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Virax Biolabs Group Limited Ordinary Shares Overview
Company information
Company Overview
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Virax Biolabs Group Limited Ordinary Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...